在视网膜衰变患者的外体序列测定揭示了一个新的候选基因ER膜蛋白复合体亚单元3ER膜蛋白复合体亚单元3
Yan-Ping Li1, Ren-Juan Shen2, You-Min Cheng1
1Laboratory for Stem Cell & Retinal Regeneration, The Eye Hospital, Basic Medical College, Wenzhou Medical University, Wenzhou, 325027, China.
Heliyon
|October 9, 2023
概括
在EMC3基因的新型突变导致遗传性视网膜变 (IRDs). 这一发现强调了EMC3的C端对其功能至关重要,并表明EMC3是视网膜疾病的新候选基因.
科学领域:
- 遗传学 遗传学 是一个
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜发育不良 (IRDs) 包含影响视力的各种遗传性疾病.
- 细胞内膜蛋白复合体 (EMC) 3 (EMC3) 亚单元3 (EMC3) 在蛋白质集成到脂质双层中发挥作用.
- 在此之前,EMC3的细胞质卡基终端的功能是未知的.
研究的目的:
- 为了研究在一个五代家族中占主导地位的IRDs的遗传基础.
- 为了确定负责观察到的视网膜退行症的特定基因和突变.
- 阐明EMC3 C端在视网膜健康和疾病中的作用.
主要方法:
- 对受影响的家庭成员进行遗传分析,以确定致病突变.
- 分离分析以确认突变与疾病表型的同时发生.
- 生物信息分析用于预测已识别的突变的结构和功能后果.
主要成果:
- 在一个具有主导IRDs的五代家族中,在EMC3基因中发现了一个插入突变 (c.768insT).
- 这种突变导致了一个框架转移,并将16个氨基酸添加到EMC3蛋白C终端 (p.L256F-fs-ext21),形成了一个新的螺旋结构.
- 该突变具有不完全的透性,但在所有受影响的个体中与疾病共同分离.
结论:
- EMC3的C端对其正常细胞功能至关重要,特别是在EMC插酶复合体内.
- 发现EMC3是一种与遗传性视网膜变相关的新型候选基因.
- 这一发现为了解某些形式的IRD背后的分子机制开辟了新的途径.
关键词:
圆杆缩症 (CRD) 是一种疾病.主导地位 主导地位 主导地位在EMC3中使用EMC3在 ER 膜蛋白复合体 (EMC) 中.遗传性视网膜损伤 (IRD) 是一种遗传性视网膜损伤.视网膜色素表皮质 (RPE) 是指视网膜的颜色表皮质.视网膜色素炎 (RP) 是一种更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.7K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
Exon Recombination
3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.6K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
